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Nuclear translocationDYRK1A is encoded in the Down's syndrome critical region on human chromosome 21, and plays an
important role in the functional and developmental regulation of many types of cells, including neuronal cells.
Here we have identiﬁed WDR68, an evolutionarily conserved protein with WD40-repeat domains, as a
cellular binding partner of DYRK1A. WDR68 was originally identiﬁed in petunia as AN11 that controls the
pigmentation of ﬂowers by stimulating the transcription of anthocyanin biosynthetic genes. Experiments
with RNA interference showed that WDR68 was indispensable for the optimal proliferation and survival of
mammalian cultured cell, andWDR68 depletion induced cell apoptosis. DYRK1A and DYRK1B, but not DYRK2,
DYRK3, or DYRK4, bound to endogenous and expressedWDR68. The N-terminal domain, but not the catalytic
kinase domain or the C-terminal domain of DYRK1A, was responsible for theWDR68 binding. Deletions in the
N-terminal or C-terminal region outside of the central WD40-repeats of WDR68 abolished its binding to
DYRK1A, suggesting that WD40 repeats are not sufﬁcient for the association with DYRK1A. Immunoﬂuo-
rescent staining revealed thatWDR68 was distributed throughout the cell. Importantly, nuclear accumulation
of WDR68 was observed upon co-expression of the wild type and a kinase-dead mutant of DYRK1A. Taken
together, these results suggest that DYRK1A binds speciﬁcally toWDR68 in cells, and that the binding, but not
the phosphorylation event, induces the nuclear translocation of WDR68.phorylation regulated protein
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DYRK (dual-speciﬁcity tyrosine-phosphorylation regulated protein
kinase/dual-speciﬁcity YAK1-related protein kinase) is a family of
mammalianprotein kinases, includingﬁvemembers;DYRK1A,DYRK1B,
DYRK2, DYRK3, andDYRK4 [1,2]. Eachmember of DYRKs has amutually
homologous (43–85% identities) catalytic domain in the middle of the
amino acid sequencewithmore divergedN- and C-terminal extensions.
The amino acid sequences of the catalytic domains of DYRKs are similar
to those of MAP kinases [3], suggesting that DYRKs might play a role in
cellular signal transduction system. For activation, MAP kinases should
be phosphorylated on both threonine and tyrosine residues in the
activation loop region by upstream MAP kinase kinases, while DYRKs
phosphorylate themselves on an intramolecular tyrosine residue in the
activation loop for correct folding, maturation, and kinase activity [4,5].
DYRK1A is expressed ubiquitously, whereas other members of DYRKs
are expressed in a tissue-speciﬁc manner [2], suggesting that eachmember of DYRKs has its own specialized function by interactingwith a
different set of protein partners.
A human gene for DYRK1A has been received considerable attention
because DYRK1A is encoded in the Down's syndrome critical region in
chromosome21 [6,7]. Indeed, overexpression ofDYRK1A is suggested to
be responsible for a part of Down's syndrome phenotypes [8–12].
DYRK1A phosphorylates NFAT (Nuclear Factor of Activated T cells) and
dysregulates NFAT by counteracting calcineurin-dependent dephos-
phorylation of NFAT which is prerequisite for the nuclear translocation
and activation of NFAT [13,14]. NFAT dysregulation is suggested to be a
part of the molecular mechanisms for developmental abnormalities in
Down's syndrome patients [13]. DYRK1A has been reported to
phosphorylate many physiologically important substrates, including
tau protein [10,11,15], glycogen synthase [16], CRY2 [17], and caspase-9
[18,19], however, the precise mechanism how the modest overexpres-
sion of DYRK1A by chromosome 21 trisomy induces pleiotropic
physiological results remains obscure.
The kinase catalytic domain of DYRK1B is 85% identical with that of
DYRK1A, and in the N-terminal domain there is a region with 80 amino
acidswhere the sequence identity is 71%betweenDYRK1AandDYRK1B.
By contrast, the C-terminal regions of these kinases differ exceedingly
both in their lengths and sequences [20].While DYRK1A is ubiquitously
expressed andpredominant in the brain, DYRK1B ismainly expressed in
muscle and testis [20]. DYRK1B plays a critical role in muscle
differentiation [21] and transmits cell survival signals [22,23]. In
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mediates some of the ras-activated signaling [25], suggesting a role for
DYRK1B in tumor progression.
WDR68 (WD-repeat protein 68) was originally identiﬁed in petunia
as a gene (AN11) responsible in a locus that controls thepigmentationof
ﬂowers by stimulating the transcription of anthocyanin biosynthetic
genes [26]. Evolutionarily conserved orthologs have been identiﬁed in
many other species, including human that do not produce anthocyanin
[26]. The amino acid sequence of human AN11 (HAN11) is 100%
identical with that of monkey, mouse, rat, dog, cow, and even chicken.
The human AN11 has 52% amino acid identity with petunia AN11 and
partially complements the an11 petuniamutant, showing the functional
conservation [26]. AN11 and its orthologs all encode a protein with ﬁve
WD40-repeats and are therefore termed collectively asWDR68.WDR68
is also referred as DCAF7, one of Ddb1- and Cul4-associated factors [27].
In general, WD40 domains are believed to facilitate interaction with
other proteins, consistent with the observation that many of WD40-
repeat proteins are found in multi-protein complexes [28,29]. All the
evidence suggests thatWDR68plays a fundamental role inmanyspecies
from plants to mammals, probably by protein–protein interactions,
although biochemical and physiological function of WDR68 remains to
be elucidated.
Two previous reports implicated a functional relationship between
WDR68 and DYRK1A. Skurat et al. biochemically followed a kinase
activity that phosphorylates Ser640 of glycogen synthase, and identiﬁed
this kinase activity as a mixture containing a short DYRK1A fragment
andWDR68 [16]. GLI1 is a transcription factor involved in theHedgehog
pathway and is phosphorylated and positively regulated by DYRK1A
[30]. Morita et al. reported that WDR68 overexpression repressed
DYRK1A-dependent GLI1 transcriptional activity [31]. It should be of
biochemical and physiological importance to examine the interaction
between DYRK1A andWDR68 at a molecular level to unveil physiolog-
ical functions of DYRK1A and WDR68.
In this report, we identiﬁed WDR68 as a major cellular binding
partner of DYRK1A. WDR68 bound to DYRK1A and DYRK1B, but not to
DYRK2, DYRK3, or DYRK4. We have newly established that WDR68 is
essential for the cell proliferation and survival. WDR68 was distributed
throughout the cell, and the binding of DYRK1A to WDR68 induced
nuclear translocation of WDR68. Based on these results, physiological
importance of the association between DYRK1A and WDR68 is
discussed.
2. Materials and methods
2.1. Reagents and antibodies
Anti-FLAG antibody (M2), HRP-conjugated anti-FLAG antibody, and
anti-FLAG-afﬁnity resin were from Sigma. HRP-conjugated anti-HA
(12CA5) and anti-Cdc37 (E-4) antibodies were from Roche and Santa
Cruz, respectively. Rabbit polyclonal antibody speciﬁc for caspase-
cleaved form of PARP (Asp214) was from Cell Signaling Technology.
Anti-Hsp90 (Heat Shock Protein 90) antibodywas described previously
[32,33]. Non-immune rabbit IgG for negative control experiments was
from SantaCruz. An antibody speciﬁc for WDR68 was raised in rabbits
against a peptide, CEDPILAYTAEGEINN, corresponding to amino acids
304–318 of human WDR68 with an additional N-terminal Cys for
conjugation. The antiserumwas puriﬁed on an afﬁnity resin conjugated
with the antigen peptide. The peptide synthesis, immunization, and
afﬁnity puriﬁcation were performed at SCRUM Inc. (Tokyo, Japan).
Hoechst 33342 was from Sigma.
pEGFP-C1 from Clontech was mutagenized in vitro by PCR with
mutagenic primers (sense sequence=5′-CGACGGTACCGCGGCCGCGG-
GATCCACC-3′). Thismutation introduced anew in-frameNot I site in the
multi-cloning site of the vector between Sac II and BamH I sites. The
nucleotide sequence of an Nhe I–BamH I fragment of the mutagenized
plasmid was conﬁrmed by direct sequencing and the Nhe I–BamH Iregion of parental pEGFP-C1 vectorwas substituted by themutagenized
Nhe I–BamH I fragment. Obtained mutagenized vector with the Not I
cloning site was referred as pEGFP-C1Not hereafter.
2.2. Molecular cloning of human DYRK family protein kinases
cDNA fragments encoding full length human DYRK1A, DYRK1B,
DYRK2, DYRK3, and DYRK4 were cloned by nested PCR ampliﬁcation
using human cDNA library plasmid (Takara) as a template. The
oligonucleotide primer sequences used were: DYRK1A: 1st PCR 5′-
CCATCAGGATGATATGAGACTTGAAAG-3′ (5′ upstream) / 2nd PCR 5′-
GATCGCGGCCGCAAAGAAGACGATGCATACAGGAGGAGA-3′ (Not I+1st
Met); DYRK1B: 1st PCR 5′-GGCCGGGCTCCCGCTCCAGGCCTCG-3′ (5′
upstream) / 2nd PCR 5′-GACTGCGGCCGCCATGGCCGTCCCACCGGGC-
CATG-3′ (Not I + 1st Met) and 5′-CAGTGCGGCCGCTCAC-
GAGCTGGCTGCTGTGCTCT-3′ (3′ end+Not I, antisense); DYRK2: 1st
PCR 5′-ACGGCAGCCCTGAAATGCATTTTCC-3′ (5′ upstream) / 2nd PCR 5′-
GATTGCGGCCGCTAAGCACACAATGAATGATCACC-3′ (Not I+1stMet) and
5′-GACGTGAGCTCAGCTAACAAGTTTTGG-3′ (3′ end antisense); DYRK3:
1st PCR 5′-ACCGGACCCCCAACTGGCGCCTCTC-3′ (5′ upstream) / 2nd PCR
5′-ATCGGCGGCCGCGATGGGAGGCACAGCTCGTGGGC-3′ (Not I+1stMet)
and 5′-GACTGCGGCCGCCTAGCTAATCAGTTTTGGCAATA-3′ (3′ end+Not
I, antisense); DYRK4: 1st PCR 5′-CTGAAGTCATCCCTGCTGTATCAGG-3′ (5′
upstream) / 2nd PCR 5′-AGCTGCGGCCGCGATGCCGGCCTCAGAGCT-
CAAGG-3′ (Not I+1st Met). The antisense primer sequence used in the
1st PCR (5′-CGGCTGGTTCTTTCCGCCTC-3′) is in the library vector
(pAP3neo) region that was used for all of the cloning of DYRKs in
common. For DYRK1A and DYRK4, an antisense primer (5′-
CGGCTGGTTCTTTCCGCCTC-3′) downstream of a Not I site of the library
vectorwas used in the 2nd PCR. As a result, the ampliﬁed PCR fragment of
DYRK coding region contains a Not I site in 5′ upstream just before the
startingATGandanotherNot I site in the3′downstreamof the stop codon.
The whole coding regions of obtained PCR fragments were conﬁrmed by
direct sequencing. In the NCBI nucleotide database, 5, 3, 2, and 2
transcription variants are found for DYRK1A, DYRK1B, DYRK2, andDYRK3
respectively, and we obtained variant 1 (763 amino acids) for DYRK1A,
variant b (589 amino acids) for DYRK1B, variant 1 (528 amino acids) for
DYRK2, and variant 1 (588 amino acids) for DYRK3.
2.3. Molecular cloning of human WDR68
A cDNA fragment encoding full length human WDR68 was cloned
by nested PCR ampliﬁcation using human cDNA library plasmid
(Takara) as a template. The oligonucleotide primer sequences used
are: 1st PCR 5′-CCACTGTTGACCCGGCCCGTACTGC-3′ (5′ upstream)
and 5′-CGGCTGGTTCTTTCCGCCTC-3′ (pAP3neo, antisense) / 2nd PCR
5′-CGATGCGGCCGCCATGTCCCTGCACGGCAAACGGA-3′ (Not I+1st
Met) and 5′-GCATGCGGCCGCCTACACTCTGAGTATCTCCAGGC-3′ (3′
end+Not I, antisense). As a result, the ampliﬁed PCR fragment of
WDR68 coding region contains a Not I site in the 5′ upstream just
before the starting ATG and another Not I site in the 3′ downstream of
the stop codon. The whole coding region was directly sequenced for
conﬁrmation.
2.4. Mammalian cell culture, transfection, cell extraction, and
immunoprecipitation
COS7 cells were cultured and transfected with mammalian expres-
sion vectors by electroporation as described before [34,35]. KB cells
were cultured in DMEM supplemented with 10% FCS in humidiﬁed air
containing 5% CO2. Cells were washed with phosphate buffered saline
and solubilized in IPW buffer (50 mM Tris–Cl, 50 mM NaCl, 100 mM
NaF, 10% glycerol, 2 mM EDTA, 2 mM sodium orthovanadate, 10 mM
sodium pyrophosphate, 1 mM dithiothreitol, 1% NP40, pH 8.0),
supplemented with 1/100 (v/v) of a mammalian protease inhibitor
cocktail (Nacalai Tesque, Kyoto Japan). The lysates were then
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recovered. Extractswith equal amounts of proteinswere incubatedwith
anti-FLAG agarose for 12 h at 4 °C. The immunocomplexes were
extensively washed and analyzed as described previously [36,37].
EZView Red protein G afﬁnity gel (Sigma) was used for WDR68
immunoprecipitation.
2.5. A large-scale isolation and mass spectrometry analysis of
DYRK1A-binding proteins
Lysate was prepared from 8 dishes (ϕ10 cm) of 3×FLAG-DYRK1A-
transfected COS7 cells, mixed with 200 μL of anti-FLAG agarose for 6 h
at 4 °C, and after extensive washing bound proteins were eluted with
0.6 mg/ml of 3×FLAG peptide as described [36,37]. Isolated proteins
were concentrated by a Microcon Centrifugal Filter (10 kDa cut off)
and analyzed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) followed by CBB protein staining. A 42 kDa band
was cut out from the gel, digested with trypsin, and analyzed by
MALDI-TOF mass spectrometry at Shimadzu Biotech (Tsukuba, Japan)
using Kratos Axima-CFRplus.
2.6. RNA interference experiments
“Stealth Select” siRNAs (HSS145522 and HSS145523) speciﬁc for
humanWDR68 were obtained from Invitrogen. Stealth RNAi Negative
Control Medium GC Duplex (Invitrogen) was used as a control. siRNA
transfection was performed using Lipofectamine RNAiMAX (Invitro-
gen) as described in a manufacturer's standard protocol with ﬁnal
12 nM of siRNA. After indicated days, cells were washed with PBS and
the numbers of attached cells were counted. Cell photos were taken
with a phase contrast microscope (Zeiss Axiovert 200 M). Cell extracts
were prepared as described above and the accumulation of cleaved
PARP as an apoptotic marker in the equal amount of proteins was
examined by western blotting analysis.
2.7. Mutants of DYRK1A
For DYRK1A deletionmutants, following PCR primers were used to
amplify the corresponding coding fragments. DYRK1A(N): 5′-
GATCGCGGCCGCAAAGAAGACGATGCATACAGGAGGAGA-3′ and 5′-
GCGGCCGCCTAACGATCCATCCACTTTTC-3′ (antisense) ; DYRK1A(K):Fig. 1. Isolation and identiﬁcation of a cellular DYRK1A binding protein. (A) A silver stainin
expressed in COS7 cells and isolated with its cellular binding partners using anti-FLAG afﬁnit
1, isolated from mock-transfected lysate; lane 2, isolated from 3×FLAG-DYRK1A expressing
amino acid sequence of human WDR68. The peptides identiﬁed by peptide mass spectrome
illustrated by boxes. (C) The reactivity of endogenous and expressed WDR68 to the anti-WD
3×FLAG-WDR68-transfected cell lysate probed with preimmune serum; lane 3, untrans
transfected cell lysate probed with the anti-WDR68 antibody. The positions of endogenous5′-GCGGCCGCGATGGATCGTTACGAAATTG-3′ and 5′-GCGGCCGCCTA-
GAAGAAACTGTGCTGCAGAG-3′ (antisense); DYRK1A(C): 5′-
GCGGCCGCCATGAAAACAGCTGATGAAGGTA-3′ and5′-GCGGCCGCTCAC-
GAGCTAGCTACAGGAC-3′ (antisense); DYARK1A(N+K): 5′-
GATCGCGGCCGCAAAGAAGACGATGCATACAGGAGGAGA-3′ and 5′-
GCGGCCGCCTAGAAGAAACTGTGCTGCAGAG-3′ (antisense); DYRK1A
(K+C): 5′-GCGGCCGCGATGGATCGTTACGAAATTG-3′ and 5′-
GCGGCCGCTCACGAGCTAGCTACAGGAC-3′ (antisense). For the kinase-
dead mutant of DYRK1A, two mutagenic primers 5′-GAATGGGTTGC-
CATCGATATAATAAAGAAC-3′ and5′-GTTCTTTATTATATCGATGGCAACC-
CATTC-3′ (antisense) were used. Site-directed in vitromutagenesis was
performed essentially as described [35].2.8. Deletion mutants of WDR68
Deletion mutants of WDR68 were produced by PCR ampliﬁcation
with following primers. Antisense primers used were WDR68(1–217):
5′-GCGGCCGCCTATTCGTAAATGATGGTGCTGTG-3′; WDR68(1–258):
5′-GCGGCCGCCTAAGGTGTGCAGGGAACCCGGAC-3′; WDR68(1–304):
5′-GCGGCCGCCTACTCAATGGCTCGGGGCATTTG-3′. A common sense
primer 5′-CGATGCGGCCGCCATGTCCCTGCACGGCAAACGGA-3′ was
used for these C-terminal deletion mutants. Sense primers used were
WDR68(150–342): 5′-GCGGCCGCCATGGAGACAGGGCAGGTGTTAG-3′;
WDR68(107–342): 5′-GCGGCCGCCATGGAGTGTTTGCTAAACAATA-3′;
WDR68(55–342): 5′-GCGGCCGCCATGAGTTCAGAGTTTATTTGCAG-3′.
A common antisense primer 5′-GCATGCGGCCGCCTACACTCTGAG-
TATCTCCAGGC-3′ was used for these N-terminal deletion mutants. For
WDR68(55–304), primers 5′-GCGGCCGCCATGAGTTCAGAGTTTATTTG-
CAG-3′ (sense) and 5′-GCGGCCGCCTACTCAATGGCTCGGGGCATTTG-3′
(antisense) were used. All the coding regions of DYRK1A and WDR68
mutants were conﬁrmed by direct sequencing.2.9. Construction of mammalian expression vectors
The Not I fragments of DYRKs, DYRK1A mutants, WDR68, and its
deletion mutants were ligated into the Not I site of p3×FLAG-CMV7.1
(Sigma), pEGFP-C1Not, and pcDNA3HA [35] to obtain mammalian
expression plasmids encoding fusion proteins with 3×FLAG-, GFP-,
and HA-tag, respectively.g pattern of complexes of DYRK1A with its associated proteins. 3×FLAG-DYRK1A was
y resin. The protein proﬁle of the immunocomplexes was shown by silver staining. Lane
lysate. The positions of DYRK1A and its associated protein (arrow) are shown. (B) The
try ﬁngerprinting analysis of the 42 kDa protein band shown with an arrow in (A) are
R68 antibody. Lane 1, untransfected cell lysate probed with preimmune serum; lane 2,
fected cell lysate probed with the anti-WDR68 antibody; lane 4, 3×FLAG-WDR68-
WDR68, 3×FLAG-WDR68, and molecular weight markers are shown.
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COS7 cells were transfected and immunostained essentially as
described [38]. Alexa488- or Alexa546-conjugated secondary antibodiesFig. 2. Effect of siRNA-induced suppression of endogenous WDR68 on the proliferation and
with control siRNA (lane 1), or two independent WDR68-speciﬁc siRNAs, RNAi-1 (lane 2, H
same numbers of cells and the amounts of WDR68 (upper panels) or control proteins (left, H
(B) The numbers of living attached COS7 cells in 35-mm dishes were daily counted. Contro
speciﬁc RNA (HSS145522); RNAi-2 (■), cells transfected with WDR68-speciﬁc RNA (HSS1
representative phase contrast photographs (upper and lower panels) of COS7 cells 2 days
apoptosis by WDR68 depletion. Effect of the two independent WDR68-speciﬁc siRNAs on th
analysis with an antibody speciﬁc for the cleaved form of PARP (upper panel). Lanes 1–4, con
control (lower panel).were used. Nuclear staining was performed by including Hoechst 33342
dye (1 μg/mL) in secondary antibody solutions. Fluorescent and phase
contrast images of cells were obtained with immersion oil using a
ﬂuorescentmicroscope (ZeissAxiophotowith PlanNEOFLUAR40× lens).apoptotic process of cultured cells. (A) COS7 (left) or KB (right) cells were transfected
SS145522) or RNAi-2 (lane 3, HSS145523). After 48 h, extracts were prepared from the
sp90; right, Cdc37) were examined by western blotting with corresponding antibodies.
l (●), cells transfected with control siRNA; RNAi-1 (▲), cells transfected with WDR68-
45523). The control siRNA-transfected cells reached full conﬂuency at day 3. (C) Two
after siRNA introduction as described in (A) and (B) are shown. (D) Induction of cell
e cleavage of an endogenous caspase substrate PARP was examined by western blotting
trol siRNA; lanes 5–8, RNAi-1; lanes 9–12, RNAi-2. The amount of Hsp90 was shown as a
Fig. 3. Association between DYRK1A and WDR68. (A) The binding of DYRK1A to WDR68
was examined by co-immunoprecipitation experiments. COS7 cells were transfectedwith
a control vector (lanes 1 and 4), a plasmid encoding 3×FLAG-DYRK1A (lanes 2 and 5) or
co-transfected with 3×FLAG-DYRK1A and HA-WDR68 (lanes 3 and 6). 3×FLAG-DYRK1A
was immunoprecipitated with anti-FLAG antibody (lanes 1–3). As controls, non-immune
serum was used (lanes 4–6). The co-immunoprecipitation of WDR68 with DYRK1A was
examined by western blotting with anti-HA antibody (upper panel). (B) The binding of
DYRK1A to WDR68 was examined by reciprocal co-immunoprecipitation experiments.
COS7 cells were transfected with a control vector (lane 1), a plasmid encoding 3×FLAG-
WDR68 (lane 2) or co-transfected with 3×FLAG-WDR68 and HA-DYRK1A (lane 3).
WDR68 was immunoprecipitated with anti-FLAG antibody, and the co-immunoprecipi-
tation of DYRK1AwithWDR68was examined by western blotting with anti-HA antibody
(upper panel). The amounts of expressed DYRK1A (middle panels) and WDR68 (lower
panels)were examinedbywesternblottingwith anti-FLAGandanti-HAantibodies (AandB).
Asterisks indicate non-speciﬁc bands.
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SDS-PAGEwas performedwith 10% acrylamide gels. Silver staining of
SDS-polyacrylamide gels was performed using 2D-Silver Stain II kit
(Daiichi Pure Chemicals). Western blotting was performed using
horseradishperoxidase-conjugated secondary antibodies (GEHealthcare
Bio-sciences) or peroxidase-conjugated primary antibodies, and detec-
tion was performed using chemiluminescent system as described [37].
3. Results
3.1. Identiﬁcation of a cellularDYRK1A-binding protein as an evolutionarily
conserved WD40-repeat protein, WDR68
Wesearched for cellular bindingpartnersofDYRK1A tounderstanda
physiological role of DYRK family protein kinases at themolecular level.
Cellular proteins bound to 3×FLAG-tagged DYRK1A were isolated and
visualized by silver staining (Fig. 1A, lane 2). As a control, lysate from
cells transfected with the empty vector was used (Fig. 1A, lane 1). As
expected, 3×FLAG-DYRK1A was detected as an 89 kDa major band
(Fig. 1A, lane 2). A 42 kDa binding protein (Fig. 1A, lane 2, arrow) was
repeatedlydetected in several independent experiments,whichwasnot
isolated in the control sample (Fig. 1A, lane 1). A large-scale isolation of
the DYRK1A-associated proteins was then conducted, and the 42 kDa
protein was analyzed bymass spectrometry. The obtained signals were
searched for NCBInr database with taxonomy of metazoa and the top
score (probability-based MOWSE score of 103) was obtained for gi|
28913537. The protein was identiﬁed as WDR68, an evolutionarily
conserved WD40-repeat protein with calculated molecular mass of
38,926. The number of mass values matched with peptide fragments
was 17 and the sequence coveragewas 56% (Fig. 1B). The result showed
that DYRK1A makes a complex with WDR68 in cells. We made an
antibody raised against a synthetic peptide corresponding to a C-
terminal region of human WDR68. The sequence is 100% identical in
WDR68 of human, monkey, mouse, cow, dog, chicken, zebraﬁsh, and
frog. The speciﬁcity of the antibody was examined by western blotting.
As shown in Fig. 1C, the antibody recognized a single 42 kDa protein in
COS7 cell lysate (lane 3). The antibody also recognized exogenously-
expressed3×FLAG-WDR68 in cell lysates (lane4),while thepreimmune
serum showed no binding (Fig. 1C, lanes 1 and 2). These results showed
that the anti-WDR68 antibody speciﬁcally recognizes endogenous and
expressed WDR68.
3.2. WDR68 is essential for the optimal cell proliferation and survival
We then examined a physiological role for WDR68 by reducing
intracellular levels of endogenous WDR68 by RNA interference experi-
ments. Two independent speciﬁc siRNAs (RNAi-1 and RNAi-2) corre-
sponding to the WDR68 mRNA sequence were introduced into
mammalian cultured cells. 48 h after the transfection, the amounts of
WDR68 in extracts of equal numbers of cells were examined by western
blotting with the anti-WDR68 antibody (Fig. 2A, upper panels). In both
COS7 (left) and KB cells (right), reduction in endogenous WDR68 was
detected (lanes2 and 3) as comparedwith cells transfectedwith a control
siRNA (lane 1). The amounts of molecular chaperones Hsp90 (left) and
Cdc37 (right) as control proteins were unchanged (Fig. 2A, lower panels).
Cells were cultured in a normal medium and the numbers of living
attached cellswere counted everyday until day 7 after siRNA transfection.
As shown in Fig. 2B, the proliferation of WDR68-reduced cells was
severely suppressed after 2 days of siRNA introduction and the cells did
not grow anymore after that, while the control cells continued to grow
until day 3 when they reached full conﬂuency. The microscopic
observation of these cells showed that the reduction in WDR68 resulted
in signiﬁcant cell rounding and ﬂoating as compared with control cells
(Fig. 2C). Almost the same results were obtained with KB cells (data not
shown). We then examined if the depletion of endogenous WDR68 bysiRNAs induced cell apoptosis. Cleavage of PARP by caspases has been
widely accepted as a speciﬁcmarker for cellular apoptotic process [39,40].
As shown in Fig. 2D upper panel, we found that treatment of cellswith the
WDR68-speciﬁc siRNAs induced accumulation of caspase-cleaved PARP
(lanes 6–8 and 10–12) while the control siRNA did not (lanes 1–4),
indicating that cells underwent apoptotic process by the depletion of
WDR68. The amounts of a control protein Hsp90 remained unchanged
(Fig. 2D, lower panel). The time course of the accumulation of caspase-
cleaved PARPagreedwellwith that of the suppressionof cell proliferation
(Fig. 2B) and of appearance of rounding/ﬂoating cells (Fig. 2C). Taken
together, these results indicated that WDR68 is essential for the optimal
division, proliferation, and survival of cells, and the depletion of WDR68
suppress the cell proliferation by inducing cell apoptosis.
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We then examined the binding between DYRK1A andWDR68 by co-
expression experiments. COS7 cells were transfected with 3×FLAG-
DYRK1A and HA-WDR68, then DYRK1A was immunoprecipitated with
anti-FLAG antibody andWDR68 in the immunocomplexes was analyzed
by western blotting with anti-HA antibody (Fig. 3A). WDR68 was co-
immunoprecipitated with DYRK1A only when both proteins were co-
expressed (Fig. 3A, upper panel, lane 3). Immunoprecipitates with a
control antibody did not containWDR68 (Fig. 3A, upper panel, lanes 4–6).
In a reciprocal co-immunoprecipitation experiment, HA-DYRK1A was
pulled down with isolated 3×FLAG-WDR68 when they were co-
expressed (Fig. 3B, upper panel, lane 3). In both experiments, the
expression levels of DYRK1A and WDR68 were shown by western
blotting analysis with anti-HA and anti-FLAG antibodies (Fig. 3, middle
and lower panels).
In the human genome, there encoded 5 members of DYRK family
protein kinases, DYRK1A, DYRK1B, DYRK2, DYRK3, and DYRK4. We
examined the binding of WDR68 to the 5 members of DYRKs by co-
expression/co-immunoprecipitation experiments (Fig. 4A). Among 5
members of DYRKs, DYRK1A (lane 3) and DYRK1B (lane 4) were found
to be associated with WDR68, but other DYRKs, DYRK2, DYRK3, and
DYRK4, did not bind to WDR68 (lanes 5–7). In addition, we found that
endogenousWDR68was associated with immunoprecipitated DYRK1A
and DYRK1B (Fig. 4B, lanes 2 and 3). Sufﬁcient amounts of all DYRKs
were expressed with their expected molecular masses (Fig. 4C). These
results showed that DYRK1A and DYRK1B, but not DYRK2, DYRK3, or
DYRK4, bind to WDR68 in cells.
3.4. The N-terminal region of DYRK1A is essential for its binding to
WDR68
DYRK1A is composed of three major domains, an N-terminal
domain (N), the kinase catalytic domain (K) in the middle of the
molecule, and a C-terminal tail (C) (Fig. 5A). The homology between
DYRK1A and DYRK1B is highest in the kinase domain (85%), while the
N-terminal and C-terminal domains contain less homologous regions
(71% and 34%, respectively). To determine which part(s) of DYRK1A is
responsible for the binding to WDR68, we made deletion mutants of
DYRK1A and examined the binding of these mutants toWDR68 by co-
immunoprecipitation experiments. As shown in Fig. 5B top panel, full
length DYRK1A (lane 3) and the N-terminal domain of DYRK1A (lane
4), but not the kinase domain (lane 5) or the C-terminal tail of DYRK1AFig. 4. Binding of DYRK1A and DYRK1B, but not DYRK2, DYRK3, or DYRK4, to WDR68. (A) The
(lane 6), and DYRK4 (lane 7), to exogenously expressed HA-WDR68 was examined b
immunoprecipitated 3×FLAG-DYRKs was revealed by western blotting with anti-HA antibod
4), DYRK3 (lane 5), and DYRK4 (lane 6) to endogenous WDR68 was examined by co-immu
with the anti-WDR68 antibody. (C) The expression proﬁles of DYRK family protein kinases(lane 6), bound toWDR68. Theessential role for theN-terminal region of
DYRK1A in the WDR68 binding was further conﬁrmed by another
experiment. The results showed that a DYRK1A mutant lacking the C-
terminal tail (DYRK1A(N+K)) (Fig. 5C,upper panel, lane4) could bind to
WDR68 as DYRK1A(N) (Fig. 5C, upper panel, lane 3), but a DYRK1A
mutant lacking the N-terminal domain (DYRK1A(K+C)) (Fig. 5C, upper
panel, lane 5) could not bind to WDR68. All the DYRK1A mutants were
expressed and immunoprecipitated as polypeptides with expected
molecular masses except DYRK1A(C) showing a slower mobility
(42 kDa) than calculated molecular masses (30 kDa) (Fig. 5B and C,
middle panels). Sufﬁcient amounts of HA-WDR68 were expressed in all
cases (Fig. 5B and C, lower panels). All these results indicated that the N-
terminal domain of DYRK1A is essential and sufﬁcient for the WDR68-
binding. We then examined if the protein kinase activity of DYRK1A is
required for the binding to WDR68. We compared the binding of
DYRK1A(WT) andDYRK1A(KD), amutantwithout the kinase activity, to
WDR68 by co-immunoprecipitation experiments. As shown in Fig. 5D,
both DYRK1A(WT) and DYRK1A(KD) bound equally well to WDR68,
suggesting that the kinase activity is not required for the binding to
WDR68. The result agreeswellwith theﬁnding thatDYRK1A(N)without
the kinase domain bound to WDR68 as shown in Fig. 5B and C.
3.5. WD40 repeats are not sufﬁcient for the binding of WDR68 to DYRK1A
As WD40 domains are often responsible for protein–protein in-
teractions, we speculated that one or several WD40 domain(s) among
ﬁve WD40 repeats in WDR68 might be responsible for the binding to
DYRK1A.Wemade deletion mutants of WDR68 as shown in Fig. 6A and
examined their DYRK1A-binding capacity by co-immunoprecipitation
experiments. Full length wild typeWDR68 was co-immunoprecipitated
with DYRK1A (Fig. 6B, upper panel, lane 4). To our surprise, the ﬁve
WD40 repeats (amino acids 55–304) were not sufﬁcient to support the
DYRK1A-binding(Fig. 6B,upper panel, lane8), andadeletion ineither the
N-terminal (aminoacids55–342, lane11)or theC-terminal (aminoacids
1–304, lane 7) region completely abolished the association of WDR68
with DYRK1A. The amounts of expressed DYRK1A did not change
(Fig. 6B, middle panel, lanes 3–11) and sufﬁcient levels of all WDR68
mutantswere expressedwith expectedmolecularmasses (Fig. 6B, lower
panel, lanes 4–11, arrows). We therefore concluded that the ﬁve WD40
domains ofWDR68 are not sufﬁcient for the binding to DYRK1A. Rather,
a stretch in both the N-terminal and C-terminal regions of themolecule,
or a complete molecular architecture of WDR68, is essential for its
binding to DYRK1A.binding of 3×FLAG-tagged DYRK1A (lane 3), DYRK1B (lane 4), DYRK2 (lane 5), DYRK3
y co-transfection/co-immunoprecipitation experiments. The binding of WDR68 to
y. (B) The binding of 3×FLAG-tagged DYRK1A (lane 2), DYRK1B (lane 3), DYRK2 (lane
noprecipitation experiments. The binding of WDR68 was revealed by western blotting
described in (B) were shown by western blotting with anti-FLAG antibody.
Fig. 5. The N-terminal domain of DYRK1A is responsible for theWDR68 binding. (A) A schematic illustration of the structure of DYRK1A and its deletion mutants used in the binding
experiments. Alignment of the structures of DYRK1A and DYRK1B is also shown. The amino acid numbers of the beginnings and endings of domains are indicated. (B) The binding of
DYRK1A(N) (lane 4), DYRK1A(K) (lane 5), and DYRK1A(C) (lane 6) to WDR68 was examined by co-transfection/co-immunoprecipitation experiments as described in Fig. 3A.
(C) The binding of DYRK1A(N) (lane 3), DYRK1A(N+K) (lane 4), and DYRK1A(K+C) (lane 5) toWDR68 was examined by co-transfection/co-immunoprecipitation experiments as
described in Fig. 3A. (D) The kinase activity of DYRK1A is not required for its binding to WDR68. The binding of DYRK1A(WT) (lane 3) and DYRK1A(KD) (lane 4) to WDR68 was
examined by co-transfection/co-immunoprecipitation experiments. In (B–D), the binding of WDR68 (upper panels), amounts of expressed and immunoprecipitated DYRK1A
(middle panels), and amounts of expressed WDR68 (lower panels) are shown. Lane 1, control without transfection; lane 2, control with WDR68 transfection without DYRK1A
transfection. Asterisks indicate non-speciﬁc bands.
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We examined the intracellular distribution of WDR68 by immuno-
ﬂuorescentmicroscopic analysis. Stainingwith the anti-WDR68antibody
revealed that endogenous WDR68 was distributed throughout the cell
(Fig. 7B, green). We observed only very faint staining by the same
concentration of control IgG (Fig. 7A), indicating the speciﬁc staining ofendogenous WDR68 with the antibody. Interestingly, cytoplasmic
staining was stronger than nuclear WDR68 in some cells, while in
other cells the staining was predominant in the nucleus, suggesting a
dynamic shuttling of WDR68 between the cytoplasm and the nucleus.
We then examined if the association with DYRK1A affects the
intracellular distribution of WDR68. GFP-WDR68 was expressed in cells
with 3×FLAG-DYRK1A or alone, and the cellular distribution of WDR68
Fig. 7. Intracellular localization ofWDR68. Subcellular localization of endogenousWDR68
wasexaminedby immunoﬂuorescentmicroscopy inCOS7cells using afﬁnity puriﬁedanti-
WDR68 antibody (B). Staining with the same concentration of non-immune IgG was
performed as a negative control (A). Two representative ﬂuorescent images are shown
(left, green) with phase contrast images (center) and nuclear images by Hoechst 33342
staining (right, blue).
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immunostaining, respectively. GFP-WDR68 was distributed throughout
the cell (Fig. 8C, green) as endogenousWDR68 (Fig. 7). In agreementwith
previous reports, overexpressed DYRK1A was present exclusively in the
nucleus (Fig. 8B,magenta). Interestingly in the presence of co-expressed
DYRK1A, WDR68 was predominantly present in the nucleus (Fig. 8D,
green) and was co-localized with DYRK1A (Fig. 8D,merged images). The
nuclear translocation ofWDR68 induced byDYRK1Awas independent of
the kinase activity of DYRK1A, because a kinase inactive mutant of
DYRK1A, DYRK1A(KD), also induced nuclear translocation of WDR68 as
wild type DYRK1A (Fig. 8E). In a reverse-tag experiments, we also
observed that 3×FLAG-WDR68becamealmost exclusively nuclear in the
presence of co-expressed GFP-DYRK1A and was co-localized with
DYRK1A in the nucleus (data not shown). The N-terminal domain of
DYRK1A contains a bipartite nuclear localization signal [4,41] and our
results indicated that the domain is responsible for the WDR68-binding
(Fig. 5). As shown in Fig. 8F, the N-terminal domain of DYRK1A was
distributed exclusively in thenucleus (magenta), and it alone induced the
nuclear accumulation of WDR68 (green). By contrast, DYRK1A(K+C)
lacks the nuclear localization signal in the N-terminal domain, and
did not accumulate in the nucleus (Fig. 8G, magenta). In addition,Fig. 6. WD40 repeats of WDR68 are not sufﬁcient for the binding to DYRK1A. (A) A
schematic illustration of the structure of WDR68 and its deletion mutants used in the
binding experiments. The amino acid numbers of the beginnings and endings of the ﬁve
WD40 domains (shown as boxes) are indicated. (B) The binding of WDR68 mutants to
DYRK1A. The WDR68 deletion mutants shown in (A) as indicated above the lane tracks
were tested for their DYRK1A binding ability by co-immunoprecipitation experiments as
described in Fig. 3A. The binding of WDR68 (upper panel), the amounts of DYRK1A
(middle panel), and the expression ofWDR68deletionmutants (lowerpanel, indicated by
arrows) are shown. An asterisk indicates a non-speciﬁc band.
Fig. 8. Nuclear translocation of WDR68 induced by DYRK1A binding. Intracellular
localization ofWDR68andDYRK1A in transfectedCOS7 cellswas visualized byﬂuorescent
microscopy. Left column, the subcellular localization of WDR68 was shown by GFP
ﬂuorescence as green; 2nd left column, the subcellular localization of DYRK1Awas shown
by anti-FLAG immunoﬂuorescence as magenta; 3rd left column, the merged images of
WDR68andDYRK1Awere shown, indicating co-localization aswhite; Right-most column,
the corresponding phase contrast images were shown. Two representative images are
shown for each sample. (A) Control cells; (B) Transfected with 3×FLAG-DYRK1A(WT);
(C) Transfected with EGFP-WDR68; (D) Co-transfected with EGFP-WDR68 and 3×FLAG-
DYRK1A(WT); (E) Co-transfected with EGFP-WDR68 and 3×FLAG-DYRK1A(KD); (F) Co-
transfected with EGFP-WDR68 and 3×FLAG-DYRK1A(N); (G) Co-transfected with EGFP-
WDR68 and 3×FLAG-DYRK1A(K+C).
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Accordingly, the cellular distribution ofWDR68 remained unchanged by
DYRK1A(K+C) overexpression (Fig. 8G, green) andWDR68 did not co-
localize with DYRK1A(K+C) (Fig. 8G, merged images). The subcellular
localization of DYRK1Awas not affected by the co-expression of WDR68
(Fig. 8).
Finally, we examined if overexpression of DYRK1A induces nuclear
accumulationof endogenousWDR68. COS7 cellswere transfected either
with a control plasmid (Fig. 9A) or with plasmid encoding 3×FLAG-
DYRK1A(WT) (Fig. 9B), and the subcellular distribution of endogenous
WDR68 was examined by immunoﬂuorescent microscopy. Strong
nuclear accumulation of endogenous WDR68 was observed only in
cells overexpressing DYRK1A (Fig. 9B, green, white arrow heads),
whereas the distribution of WDR68 in other cells in the same
microscopic ﬁeld remained unchanged. We noticed that WDR68 did
not accumulate in the nucleus in some of DYRK1A-overexpressing cells,
suggesting an additional factor that controls the subcellular localization
of endogenous WDR68. Taken together, all of these results shown in
Figs. 8 and 9 indicate that DYRK1A binds toWDR68 and induces nuclear
accumulation of WDR68 in a phosphorylation-independent manner,
and WDR68 exists in the nucleus as complexes with DYRK1A.
4. Discussion
4.1. The binding of WDR68 to DYRK1A and DYRK1B
In this paper, we identiﬁed WDR68 as a DYRK1A binding protein
and analyzed the association between WDR68 and DYRK1A in detail.
In addition, the physiological importance of WDR68 for cell
proliferation and survival was established. Our results are in good
agreement with and further extend two previous reports that
implicated a functional relationship between WDR68 and DYRK1A
as described in Introduction [16,31]. During this study, a physical
association between WDR68 and DYRK1B of zebraﬁsh in an in vitro
translational assay [42] and a scaffold function of Han11 (WDR68) for
MEKK1 and DYRK1A·HIPK2 [43] have been reported. All of these
observations can well be explained by our present ﬁnding showing
that WDR68 binds to the N-terminal domain of DYRK1A and DYRK1B,
which is not well conserved in DYRK2, DYRK3, or DYRK4. It should be
natural to consider that WDR68 and DYRK1A·DYRK1B constitute a
multi-facet complex regulating many cellular functions.
4.2. Subcellular localization and physiological function of WDR68
Our siRNA results demonstrated that mammalian cells cannot
grow or survive withoutWDR68 (Fig. 2). WDR68 suppression induced
cell rounding and ﬂoating in themedium, with concomitant induction
of cell apoptosis as indicated by the accumulation of caspase-cleaved
PARP (Fig. 2D), and most cells died 5 days after introduction of
WDR68-targeting siRNAs. The cell death caused by WDR68 suppres-
sion could not be rescued by concomitant overexpression of DYRK1A
(data not shown), suggesting that DYRK1A is not a sole functional
target of WDR68. The amino acid sequences of WDR68 are highly
conserved among species, and WDR68 might therefore function in a
fundamental biological process essential for many species from plants
to human. WDR68 is crucial for expression of anthocyanin synthetic
enzymes in plant [26,44] and plays an important function in
craniofacial development in zebraﬁsh [45], suggesting a possible
role for WDR68 in regulating gene expression. However, the
molecular basis why such diverged physiological functions could be
ascribed to WDR68 remains elusive.
GFP-tagged zebraﬁsh WDR68 was reported to be in the nucleus
when expressed in 293 cells [45], whereas petuniaWDR68was shown
to be cytosolic by fractionation experiments [26]. HA-tagged human
WDR68was reported to be present in both the nucleus and cytoplasm
in transfected 293T cells [31]. In this study, our results demonstrate
Fig. 9. Nuclear accumulation of endogenous WDR68 by DYRK1A overexpression. Subcellular localization of endogenous WDR68 and expressed DYRK1A was examined by
immunoﬂuorescent microscopy using anti-WDR68 antibody and anti-FLAG antibody, respectively. (A) Transfected with a control vector; (B) transfected with 3×FLAG-DYRK1A
(WT) plasmid. Two representative ﬂuorescent images for WDR68 (left, green) and DYRK1A (2nd left, magenta) are shown with nuclear images by Hoechst 33342 staining (3rd left,
blue) and phase contrast images (right-most).
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by immunoﬂuorescence staining (Figs. 7 and 9). WDR68 should have
a role and speciﬁc partners both in the cytoplasm and the nucleus. We
showed that overexpression of DYRK1A induced translocation of
WDR68 into the cell nucleus where WDR68 was co-localized with
DYRK1A (Figs. 8 and 9). In addition, we observed the physical
association (Fig. 5D) and nuclear accumulation (Fig. 8) of WDR68
with a kinase-dead mutant of DYRK1A, therefore, the binding, but not
the phosphorylation event, might induce the nuclear accumulation of
WDR68 by DYRK1A. This suggests that DYRK1A recruits WDR68 into
the nucleus by the association, or that DYRK1A might function as a
nuclear anchoring protein for WDR68.4.3. The WDR68-binding site in DYRK1A
DYRK1A is composed of the N-terminal domain, the central
protein kinase catalytic domain, and the C-terminal domain. Analyses
with deletion mutants showed that the N-terminal domain is the
WDR68-binding site (Fig. 5). One of two nuclear localization signals of
DYRK1A was mapped within the N-terminal region [2,41], but no
other function has been ascribed to the N-terminal domain. We
showed that the DYRK1A N-terminal domain alone was localized in
the nucleus and induced the nuclear accumulation of WDR68 upon
co-expression (Fig. 8F). Five members of the DYRK kinases share a
high degree of conservation in the catalytic domain, but are divergent
in their N- and C-terminal domains. Our results show that DYRK1A
and DYRK1B, but not DYRK2, DYRK3, or DYRK4, bound to WDR68
(Fig. 4). Indeed, a part of the N-terminal domain of DYRK1A shows
71% identity with that of DYRK1B (see Fig. 5), suggesting that this
region is the WDR68-binding site within both DYRK1A and DYRK1B.
Overexpression of WDR68 did not inﬂuence tyrosine phosphorylation
or kinase activity of DYRK1A (data not shown), suggesting that the
binding of WDR68 is not involved in the folding process or the
catalytic regulation of DYRK1A. Therefore, WDR68 might not function
as a direct activator or suppressor of DYRKs. However, we cannot rule
out a possibility that abundant endogenous WDR68 is sufﬁcient for
supporting DYRK1A and DYRK1B.4.4. The DYRK1A-binding activity and WD40 repeats of WDR68
WDR68 contains ﬁve sets of WD40 domains (Fig. 6). WD40
repeating units are believed to serve as a scaffold for simultaneous
interactions with different proteins [28,29,46]. Crystal structures of
several WD40 proteins, including signal-transducing heterotrimeric G
protein β [47,48], SCFFbw7 ubiquitin ligase [49], and RACK1 [50,51]
have been determined. Most WD40 proteins consist of 7 WD-repeats
and fold into a 7-bladed β-propeller structure. Our results demon-
strate that the ﬁve WD40 repeats per se are not sufﬁcient for the
DYRK1A interaction (Fig. 6). The N-terminal and C-terminal domains
might form together a DYRK1A binding site, while WD40 repeats
might be responsible for the binding to other proteins. Most known
propeller ring proteins appear to have some mechanism for holding
the ring closed [28]. The N-terminal and C-terminal extensions thus
might function to keep a possible 5-bladed propeller structure of
WDR68 stabilized and closed. Coronin-1 forms a 7-bladed β-propeller
composed of its ﬁveWD40 repeats and two additional blades encoded
in a sequence that lacks any homology to the canonical WD40 motif
[52]. Similarly, WDR68 may form a 7-bladed β-propeller structure
that requires the N-terminal and C-terminal extensions for two blades
in addition to the ﬁveWD40 blades. Structural analysis of WDR68 will
shed light on the interaction with DYRK1A at a molecular level.
4.5. Down's syndrome and DYRK1A
Down's syndrome, the most common genetic disorder leading to
mental retardation with neurodevelopmental abnormalities, is caused
by the presence of all or a part of triplicated chromosome 21. DYRK1A is
encoded in themost critical region (21q–22) [6,7], and transgenic mice
overexpressing DYRK1A exhibit hyperactivity and impaired neuromo-
tor development aswell as learning andmemory defects [8,9,53]. Many
of these phenotypes are recovered by normalizing DYRK1A protein
levels with DYRK1A-targeting siRNA [54]. Aberrant overexpression of
DYRK1A in trisomy 21 carriers should therefore contribute to mental
retardation and other developmental disorders. In this report, we
found that overexpression of DYRK1A induced nuclear translocation
of WDR68 in a kinase-activity independent manner (Figs. 8 and 9).
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overexpressedDYRK1A toWDR68 in the nucleusmight induce aberrant
gene expression. This could be a part of mechanism that DYRK1A
overexpression induces pleiotropic phenotypes observed in Down's
syndrome patient. The speciﬁc facial features are among the character-
istics of Down's syndrome, and an important role in craniofacial
development was suggested for DYRK1A using mouse model [13] and
also for WDR68 by zebraﬁsh screening [45], further supporting our
hypothesis thatDYRK1AandWDR68 should cooperativelywork in cells.
Although there should be additional mechanism to control the function
and the subcellular distribution of WDR68, our results suggest the
functional and physiological importance of the binding between
DYRK1A and WDR68 to understand the biology of Down's syndrome
and to unveil cellular functions of DYRK1A andWDR68 at themolecular
level. Recently, speciﬁc inhibitors against DYRK1A [55] and a WD40
protein Cdc4SCF[56] were reported. Inhibition of DYRK1A and/or
WDR68 by low-molecular weight compounds can be a possible way
to suppress multiple outcomes caused by DYRK1A overexpression in
cells and in human bodies.
5. Conclusions
We identiﬁedWDR68, an evolutionarily conservedWD40-protein, as
a cellular binding partner of DYRK1A. WDR68 was indispensable for the
optimal proliferation and survival of mammalian cells. DYRK1A and
DYRK1B, but not DYRK2, DYRK3, or DYRK4, bound to WDR68. The N-
terminal domain, but not the catalytic kinase domain or the C-terminal
domain ofDYRK1A,was responsible for theWDR68binding.WDR68was
distributed throughout the cell, and overexpression of DYRK1A resulted
in nuclear accumulation of WDR68 in a kinase activity-independent
manner. These results suggest that DYRK1A binds speciﬁcally toWDR68
in cells, thereby inducingnuclear translocation ofWDR68. The binding of
overexpressed DYRK1A to WDR68 in the nucleus might be a part of the
molecularmechanismunderlying thepleiotropic pathological alterations
observed in Down's syndrome patient.
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